The pharmacist's role in the management of the irradiated individual is
to help lessen oral discomfort and morbidity stemming from complications
of head and neck radiotherapy.
Novel drug delivery systems have
been extensively investigated in an effort to improve the therapeutic
effectiveness and safety profile of traditional chemotherapeutic agents.